269 related articles for article (PubMed ID: 23222812)
21. Genetic predisposition and chromosome instability in neuroblastoma.
Tonini GP; Capasso M
Cancer Metastasis Rev; 2020 Mar; 39(1):275-285. PubMed ID: 31927719
[TBL] [Abstract][Full Text] [Related]
22. BARD1 germline variants induce haploinsufficiency and DNA repair defects in neuroblastoma.
Randall MP; Egolf LE; Vaksman Z; Samanta M; Tsang M; Groff D; Evans JP; Rokita JL; Layeghifard M; Shlien A; Maris JM; Diskin SJ; Bosse KR
J Natl Cancer Inst; 2024 Jan; 116(1):138-148. PubMed ID: 37688570
[TBL] [Abstract][Full Text] [Related]
23. Functional Polymorphisms in
Shi J; Yu Y; Jin Y; Lu J; Zhang J; Wang H; Han W; Chu P; Tai J; Chen F; Ren H; Guo Y; Ni X
J Cancer; 2019; 10(10):2153-2160. PubMed ID: 31258718
[TBL] [Abstract][Full Text] [Related]
24. [Association between single nucleotide polymorphisms of BARD 1 gene and susceptibility of early-onset breast cancer in Uygur women in Xinjiang].
Sun G; Wang JT; Ma BL; Geng ZL; Ren GH; Shan MH; Ma B; Ma LL; Wang Y
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):341-7. PubMed ID: 22883453
[TBL] [Abstract][Full Text] [Related]
25. RSRC1 and CPZ gene polymorphisms with neuroblastoma susceptibility in Chinese children.
Tang J; Liu W; Zhu J; Zhang J; Wang FH; Liang JH; Zeng JH; Wang H; Xia H; He J
Gene; 2018 Jul; 662():83-87. PubMed ID: 29653227
[TBL] [Abstract][Full Text] [Related]
26. The functional variant rs34330 of CDKN1B is associated with risk of neuroblastoma.
Capasso M; McDaniel LD; Cimmino F; Cirino A; Formicola D; Russell MR; Raman P; Cole KA; Diskin SJ
J Cell Mol Med; 2017 Dec; 21(12):3224-3230. PubMed ID: 28667701
[TBL] [Abstract][Full Text] [Related]
27. Correlation of BARD1 gene polymorphisms with risk of neuroblastoma: a meta-analysis.
Chen S; Xu D; Huang R; Lin Y; Li L
Nucleosides Nucleotides Nucleic Acids; 2024 Apr; ():1-19. PubMed ID: 38619196
[TBL] [Abstract][Full Text] [Related]
28. Integrative genomics identifies LMO1 as a neuroblastoma oncogene.
Wang K; Diskin SJ; Zhang H; Attiyeh EF; Winter C; Hou C; Schnepp RW; Diamond M; Bosse K; Mayes PA; Glessner J; Kim C; Frackelton E; Garris M; Wang Q; Glaberson W; Chiavacci R; Nguyen L; Jagannathan J; Saeki N; Sasaki H; Grant SF; Iolascon A; Mosse YP; Cole KA; Li H; Devoto M; McGrady PW; London WB; Capasso M; Rahman N; Hakonarson H; Maris JM
Nature; 2011 Jan; 469(7329):216-20. PubMed ID: 21124317
[TBL] [Abstract][Full Text] [Related]
29. Genome-wide pathway analysis in neuroblastoma.
Lee YH; Kim JH; Song GG
Tumour Biol; 2014 Apr; 35(4):3471-85. PubMed ID: 24293394
[TBL] [Abstract][Full Text] [Related]
30. [Association between single nucleotide polymorphism of BARD1 gene and BRCA1 gene mutation in epithelial ovarian cancer].
Liu WL; Zhao JZ; Wang ZZ; Dong B; Hou YY; Wu XX; Guo YJ
Zhonghua Fu Chan Ke Za Zhi; 2017 Jun; 52(6):403-410. PubMed ID: 28647964
[No Abstract] [Full Text] [Related]
31. Germline pathogenic variants in neuroblastoma patients are enriched in BARD1 and predict worse survival.
Kim J; Vaksman Z; Egolf LE; Kaufman R; Evans JP; Conkrite KL; Danesh A; Lopez G; Randall MP; Dent MH; Farra LM; Menghani NL; Dymek M; Desai H; Hausler R; Hicks B; Auvil JG; Gerhard DS; Hakonarson H; Maxwell KN; Cole KA; Pugh TJ; Bosse KR; Khan J; Wei JS; Maris JM; Stewart DR; Diskin SJ
J Natl Cancer Inst; 2024 Jan; 116(1):149-159. PubMed ID: 37688579
[TBL] [Abstract][Full Text] [Related]
32. Genetic Analysis in African American Children Supports Ancestry-Specific Neuroblastoma Susceptibility.
Testori A; Vaksman Z; Diskin SJ; Hakonarson H; Capasso M; Iolascon A; Maris JM; Devoto M
Cancer Epidemiol Biomarkers Prev; 2022 Apr; 31(4):870-875. PubMed ID: 35131881
[TBL] [Abstract][Full Text] [Related]
33.
Formicola D; Lasorsa VA; Cantalupo S; Testori A; Cardinale A; Avitabile M; Diskin S; Iolascon A; Capasso M
HGG Adv; 2023 Jan; 4(1):100158. PubMed ID: 36425957
[TBL] [Abstract][Full Text] [Related]
34. Genome-wide linkage analysis to identify genetic modifiers of ALK mutation penetrance in familial neuroblastoma.
Devoto M; Specchia C; Laudenslager M; Longo L; Hakonarson H; Maris J; Mossé Y
Hum Hered; 2011; 71(2):135-9. PubMed ID: 21734404
[TBL] [Abstract][Full Text] [Related]
35. Replication of GWAS-identified systemic lupus erythematosus susceptibility genes affirms B-cell receptor pathway signalling and strengthens the role of IRF5 in disease susceptibility in a Northern European population.
Järvinen TM; Hellquist A; Zucchelli M; Koskenmies S; Panelius J; Hasan T; Julkunen H; D'Amato M; Kere J
Rheumatology (Oxford); 2012 Jan; 51(1):87-92. PubMed ID: 22039224
[TBL] [Abstract][Full Text] [Related]
36. Replication of the 4p16 susceptibility locus in congenital heart disease in Han Chinese populations.
Zhao B; Lin Y; Xu J; Ni B; Da M; Ding C; Hu Y; Zhang K; Yang S; Wang X; Yu S; Chen Y; Mo X; Liu J; Shen H; Sha J; Ma H
PLoS One; 2014; 9(9):e107411. PubMed ID: 25215500
[TBL] [Abstract][Full Text] [Related]
37. LMO1 polymorphisms and the risk of neuroblastoma: Assessment of meta-analysis of case-control studies.
Hashemi M; Sarabandi S; Karami S; Śmieja J; Moazeni-Roodi A; Ghavami S; Łos MJ
J Cell Mol Med; 2020 Jan; 24(2):1160-1168. PubMed ID: 31830377
[TBL] [Abstract][Full Text] [Related]
38.
Li Y; Lu T; Wang J; Zhuo Z; Miao L; Yang Z; Zhang J; Cheng J; Zhou H; Li S; Li L; He J; Li A
Aging (Albany NY); 2021 Dec; 13(23):25426-25439. PubMed ID: 34897032
[TBL] [Abstract][Full Text] [Related]
39. BARD1 variants are not associated with breast cancer risk in Australian familial breast cancer.
Gorringe KL; Choong DY; Visvader JE; Lindeman GJ; Campbell IG
Breast Cancer Res Treat; 2008 Oct; 111(3):505-9. PubMed ID: 17972171
[TBL] [Abstract][Full Text] [Related]
40. Loss of DNA Damage Response in Neuroblastoma and Utility of a PARP Inhibitor.
Takagi M; Yoshida M; Nemoto Y; Tamaichi H; Tsuchida R; Seki M; Uryu K; Nishii R; Miyamoto S; Saito M; Hanada R; Kaneko H; Miyano S; Kataoka K; Yoshida K; Ohira M; Hayashi Y; Nakagawara A; Ogawa S; Mizutani S; Takita J
J Natl Cancer Inst; 2017 Nov; 109(11):. PubMed ID: 29059438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
